Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Sep 15, 2022; 14(9): 1758-1770
Published online Sep 15, 2022. doi: 10.4251/wjgo.v14.i9.1758
Published online Sep 15, 2022. doi: 10.4251/wjgo.v14.i9.1758
Table 1 Clinical characteristics of enrolled patients
| Characteristics | Total (41) | EdR + CRT (28) | EdR (13) | P value |
| Age, median (range), yr | 69 (38-91) | 67 (38-87) | 74 (61-91) | 0.519 |
| Sex, n (%) | 0.524 | |||
| Male | 25 (61) | 18 (43.9) | 7 (17.1) | |
| Female | 16 (39) | 10 (24.4) | 6 (14.6) | |
| Location, n (%) | 0.184 | |||
| ≤ 25 cm | 22 (54) | 17 (41.5) | 5 (12.5) | |
| > 25 cm | 19 (46) | 11 (26.8) | 8 (19.2) | |
| TNM stage, n (%) | 0.400 | |||
| IB | 16 (39) | 10 (24) | 6 (15) | |
| IIA | 18 (43.9) | 14 (34.1) | 4 (9.8) | |
| IIB | 1 (2.4) | 1 (2.4) | 0 (0) | |
| IIIA | 1 (2.4) | 0 (0) | 1 (2.4) | |
| IIIB | 3 (7.3) | 2 (4.9) | 1 (2.4) | |
| IVA | 0 (0) | 0 (0) | 0 (0) | |
| IVB | 2 (4.9) | 1 (2.4) | 1 (2.4) | |
| T stage, n (%) | 0.348 | |||
| T1b | 17 (41.5) | 11 (26.8) | 6 (14.7) | |
| T2 | 23 (56.1) | 17 (41.5) | 6 (14.6) | |
| T3 | 1 (2.4) | 0 (0) | 1 (2.4) | |
| T4 | 0 (0) | 0 (0) | 0 (0) | |
| N stage, n (%) | 0.52 | |||
| N0 | 34 (82.9) | 24 (58.5) | 10 (24.4) | |
| N1 | 2 (4.9) | 1 (2.45) | 1 (2.45) | |
| N2 | 5 (12.2) | 3 (7.3) | 2 (4.9) | |
| M stage, n (%) | 0.539 | |||
| M0 | 39 (95.1) | 27 (65.9) | 12 (29.2) | |
| M1 | 2 (4.9) | 1 (2.45) | 1 (2.45) |
- Citation: Ren LH, Zhu Y, Chen R, Shrestha Sachin M, Lu Q, Xie WH, Lu T, Wei XY, Shi RH. Endoscopic debulking resection with additive chemoradiotherapy: Optimal management of advanced inoperable esophageal squamous cell carcinoma. World J Gastrointest Oncol 2022; 14(9): 1758-1770
- URL: https://www.wjgnet.com/1948-5204/full/v14/i9/1758.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i9.1758